Total Payments
$814.53
2024 Payments
$335.57
Companies
19
Transactions
34
Medicare Patients
663
Medicare Billing
$40,582
Payment Breakdown by Category
Food & Beverage$814.53 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $814.53 | 34 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Amgen Inc. | $255.09 | 4 | $0 (2024) |
| GlaxoSmithKline, LLC. | $114.22 | 6 | $0 (2024) |
| ABBVIE INC. | $67.66 | 4 | $0 (2024) |
| Lilly USA, LLC | $65.71 | 3 | $0 (2023) |
| Novo Nordisk Inc | $33.74 | 2 | $0 (2024) |
| SANOFI PASTEUR INC. | $31.52 | 1 | $0 (2022) |
| Merck Sharp & Dohme LLC | $30.74 | 2 | $0 (2024) |
| PFIZER INC. | $28.19 | 1 | $0 (2024) |
| Abbott Laboratories | $24.62 | 1 | $0 (2022) |
| Hologic, LLC | $21.45 | 1 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $335.57 | 12 | Amgen Inc. ($143.96) |
| 2023 | $176.50 | 6 | Amgen Inc. ($111.13) |
| 2022 | $149.56 | 8 | SANOFI PASTEUR INC. ($31.52) |
| 2021 | $152.90 | 8 | Lilly USA, LLC ($44.27) |
All Payment Transactions
34 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | Tris Pharma Inc | Onyda XR (Drug) | Food and Beverage | In-kind items and services | $20.97 | General |
| Category: ADHD | ||||||
| 09/10/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $16.40 | General |
| 09/04/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $16.98 | General |
| Category: NEUROSCIENCE | ||||||
| 08/23/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug), TRELEGY ELLIPTA | Food and Beverage | In-kind items and services | $31.57 | General |
| Category: RESPIRATORY | ||||||
| 06/20/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $28.19 | General |
| Category: PAIN | ||||||
| 04/30/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $14.20 | General |
| Category: IMMUNOLOGY | ||||||
| 04/04/2024 | GlaxoSmithKline, LLC. | BEXSERO (Biological), PEDIARIX, ROTARIX | Food and Beverage | In-kind items and services | $13.73 | General |
| Category: VACCINES | ||||||
| 04/03/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $15.25 | General |
| Category: Biological | ||||||
| 03/13/2024 | Merck Sharp & Dohme LLC | GARDASIL (Biological), VAXNEUVANCE, GARDASIL 9 | Food and Beverage | In-kind items and services | $14.61 | General |
| Category: VACCINE | ||||||
| 02/29/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $19.71 | General |
| Category: NEUROSCIENCE | ||||||
| 02/01/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $125.01 | General |
| Category: Inflammation | ||||||
| 01/29/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $18.95 | General |
| Category: Inflammation | ||||||
| 12/06/2023 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $94.18 | General |
| Category: Cardiology | ||||||
| 08/17/2023 | GlaxoSmithKline, LLC. | AREXVY (Drug), TRELEGY ELLIPTA, SHINGRIX | Food and Beverage | In-kind items and services | $16.20 | General |
| Category: RESPIRATORY | ||||||
| 08/09/2023 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $16.95 | General |
| Category: Inflammation | ||||||
| 06/01/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $21.44 | General |
| Category: Diabetes | ||||||
| 05/30/2023 | Seqirus USA Inc | Fluad Quadrivalent (Biological), FLUCELVAX QUADRIVALENT | Food and Beverage | In-kind items and services | $13.08 | General |
| Category: Vaccines | ||||||
| 04/14/2023 | Cranial Technologies, Inc | Doc Band (Device) | Food and Beverage | Cash or cash equivalent | $14.65 | General |
| Category: Cranial Orthotic | ||||||
| 12/21/2022 | Kowa Pharmaceuticals America, Inc. | Seglentis (Drug) | Food and Beverage | Cash or cash equivalent | $12.76 | General |
| Category: Pain Management | ||||||
| 10/04/2022 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $17.34 | General |
| Category: Diabetes | ||||||
| 07/25/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $16.58 | General |
| Category: NEUROSCIENCE | ||||||
| 07/13/2022 | GlaxoSmithKline, LLC. | SHINGRIX (Biological) | Food and Beverage | In-kind items and services | $17.91 | General |
| Category: VACCINES | ||||||
| 05/12/2022 | Merck Sharp & Dohme LLC | GARDASIL 9 (Biological), PNEUMOVAX 23, VAXNEUVANCE | Food and Beverage | In-kind items and services | $16.13 | General |
| Category: VACCINE | ||||||
| 04/12/2022 | Abbott Laboratories | FREESTYLE LIBRE 2 (Device) | Food and Beverage | In-kind items and services | $24.62 | General |
| Category: Diabetes Care | ||||||
| 03/24/2022 | SANOFI PASTEUR INC. | MENQUADFI (Biological), VAXELIS | Food and Beverage | In-kind items and services | $31.52 | General |
| Category: Vaccines | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 158 | 216 | $29,580 | $9,775 |
| 2022 | 6 | 167 | 239 | $33,235 | $10,165 |
| 2021 | 8 | 215 | 384 | $41,997 | $13,891 |
| 2020 | 5 | 123 | 167 | $20,780 | $6,751 |
Total Patients
663
Total Services
1,006
Medicare Billing
$40,582
Procedure Codes
25
All Medicare Procedures & Services
25 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 45 | 85 | $13,600 | $3,871 | 28.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 27 | 27 | $5,130 | $2,969 | 57.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 21 | 30 | $6,900 | $1,911 | 27.7% |
| G0442 | Annual alcohol misuse screening, 5 to 15 minutes | Office | 2023 | 28 | 28 | $720.00 | $438.90 | 61.0% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 24 | 24 | $1,800 | $375.42 | 20.9% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 13 | 22 | $1,430 | $209.44 | 14.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 45 | 91 | $13,720 | $4,619 | 33.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 48 | 68 | $15,640 | $4,599 | 29.4% |
| G0442 | Annual alcohol misuse screening, 15 minutes | Office | 2022 | 24 | 24 | $600.00 | $389.42 | 64.9% |
| G0444 | Annual depression screening, 15 minutes | Office | 2022 | 23 | 23 | $1,725 | $366.27 | 21.2% |
| 83036 | Hemoglobin a1c level | Office | 2022 | 12 | 16 | $1,040 | $153.15 | 14.7% |
| 81003 | Automated urinalysis test | Office | 2022 | 15 | 17 | $510.00 | $37.57 | 7.4% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 55 | 93 | $21,390 | $6,386 | 29.9% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 48 | 103 | $13,390 | $4,879 | 36.4% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time per calendar month | Office | 2021 | 12 | 76 | $3,192 | $1,702 | 53.3% |
| G0442 | Annual alcohol misuse screening, 15 minutes | Office | 2021 | 19 | 19 | $475.00 | $310.24 | 65.3% |
| G0444 | Annual depression screening, 15 minutes | Office | 2021 | 19 | 19 | $1,425 | $310.24 | 21.8% |
| 83036 | Hemoglobin a1c level | Office | 2021 | 12 | 14 | $910.00 | $135.94 | 14.9% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2021 | 39 | 45 | $765.00 | $135.00 | 17.6% |
| 81003 | Automated urinalysis test | Office | 2021 | 11 | 15 | $450.00 | $33.75 | 7.5% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 41 | 75 | $9,105 | $3,587 | 39.4% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 34 | 41 | $9,430 | $2,754 | 29.2% |
| G0444 | Annual depression screening, 15 minutes | Office | 2020 | 13 | 13 | $975.00 | $208.59 | 21.4% |
| 83036 | Hemoglobin a1c level | Office | 2020 | 13 | 13 | $845.00 | $126.23 | 14.9% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2020 | 22 | 25 | $425.00 | $75.00 | 17.6% |
About Wendy Sharp, NP
Wendy Sharp, NP is a Family healthcare provider based in Cleveland, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/23/2010. The National Provider Identifier (NPI) number assigned to this provider is 1043537509.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Wendy Sharp, NP has received a total of $814.53 in payments from pharmaceutical and medical device companies, with $335.57 received in 2024. These payments were reported across 34 transactions from 19 companies. The most common payment nature is "Food and Beverage" ($814.53).
As a Medicare-enrolled provider, Sharp has provided services to 663 Medicare beneficiaries, totaling 1,006 services with total Medicare billing of $40,582. Data is available for 4 years (2020–2023), covering 25 distinct procedure/service records.
Ad
Practice Information
- Specialty Family
- Location Cleveland, TX
- Active Since 04/23/2010
- Last Updated 09/07/2012
- Taxonomy Code 363LF0000X
- Entity Type Individual
- NPI Number 1043537509
Products in Payments
- Otezla (Drug) $160.91
- Repatha (Biological) $94.18
- VRAYLAR (Drug) $67.66
- AREXVY (Drug) $47.77
- MENQUADFI (Biological) $31.52
- NURTEC ODT (Drug) $28.19
- EMGALITY (Drug) $25.02
- FREESTYLE LIBRE 2 (Device) $24.62
- THINPREP 2000 PROCESSOR (Device) $21.45
- MOUNJARO (Drug) $21.44
- Onyda XR (Drug) $20.97
- ANORO ELLIPTA (Drug) $20.61
- TRULICITY (Drug) $19.25
- SHINGRIX (Biological) $17.91
- Rybelsus (Drug) $17.34
- ADHANSIA XR (Drug) $17.00
- Dayvigo (Drug) $16.44
- GARDASIL 9 (Biological) $16.13
- Veozah (Drug) $15.25
- Doc Band (Device) $14.65
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Doctors in Cleveland
Jateum Blackburn, Fnp-C, FNP-C
Family — Payments: $113,934
Family $113,934
Jodi Rose, Np, NP
Family — Payments: $52,180
Family $52,180
Mrs. Tina Corkwell, Cnp, CNP
Family — Payments: $48,521
Family $48,521
Christina Gast, Np, NP
Family — Payments: $41,325
Family $41,325
Sarah Demko, Cnp, CNP
Family — Payments: $26,912
Family $26,912
Barton Nakdimen, Aprn-Bc, APRN-BC
Family — Payments: $10,749
Family $10,749